Forward Pharma A/S
FWPAY · OTC
6/30/2022 | 12/31/2021 | 6/30/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $65,275 | $70,770 | $75,097 | $79,087 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $138 | $140 | $372 | $287 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $65,641 | $71,402 | $75,693 | $79,711 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $3 | $3 | $3 |
| Total NC Assets | $3 | $3 | $3 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $65,644 | $71,405 | $75,696 | $79,714 |
| Liabilities | – | – | – | – |
| Payables | $80 | $70 | $30 | $476 |
| Short-Term Debt | $2,945 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $536 | $538 | $557 | $594 |
| Total Curr. Liab. | $3,561 | $608 | $587 | $1,070 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,561 | $608 | $587 | $1,070 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $158 | $157 | $157 | $154 |
| Retained Earnings | -$16,422 | -$16,716 | -$15,856 | -$14,825 |
| AOCI | $78,347 | $87,356 | $90,808 | $93,315 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $62,083 | $70,797 | $75,109 | $78,644 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $65,644 | $71,405 | $75,696 | $79,714 |
| Net Debt | -$62,330 | -$70,770 | -$75,097 | -$79,087 |